Colpman David 4
4 · AZIYO BIOLOGICS, INC. · Filed Oct 24, 2022
Insider Transaction Report
Form 4
Colpman David
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-10-20+28,513→ 28,513 totalExercise: $7.16Exp: 2032-10-20→ Class A Common Stock (28,513 underlying)
Footnotes (1)
- [F1]The option vests annually in three equal installments of one-third each, on each of the first three anniversaries of the grant date, such that the option shall be fully vested and exercisable on October 20, 2025.